These pathways mainly involve the PI3K/AKT signaling pathway, Proteoglycans in cancer, p53 signaling pathway, etc., suggesting that HDH-SBH drug pair may exert anti-NPC effects through multiple cancer-related pathways. Here, AKT1 is linked to cancer.